Peng, Linqing – Trademark Portfolio

Entity Type: 01

Peng, Linqing holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DR.NOVA and GIFTPARTY. The owner is based in Hunan Province.

No. 64, Yijiawan Group, Xitang Village

Lukou Town, Zhuzhou Count

Hunan Province 412100 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GIFTPARTY
GIFTPARTY
Registered 2024
DR.NOVA
DR.NOVA
Registered 2024

Trademark Classifications

Peng, Linqing's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Peng, Linqing have?

Peng, Linqing has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Peng, Linqing file in?

Peng, Linqing files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 5 (Pharmaceuticals). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Peng, Linqing's most well-known trademarks?

Peng, Linqing's registered trademark portfolio includes well-known marks such as DR.NOVA and GIFTPARTY. These are among 2 currently registered trademarks in the portfolio.

What is Peng, Linqing's trademark registration success rate?

Peng, Linqing has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.